Physician profile
Mitchell Hollander
NPI 1487619458
$13,719.49
in general payments reported to CMS, 2019-2025
26 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,081 · 2020: $5,308 · 2021: $127 · 2022: $46.17 · 2023: $549 · 2024: $358 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Gpo, LLC | $6,305.51 | 2019 | |
| Srs Medical Systems, INC. | $5,000.00 | 2020 | |
| Ferring Pharmaceuticals INC. | $551.93 | 2019-2020 | |
| Medtronic, INC. | $202.52 | 2023-2024 | Interstim |
| Janssen Biotech, INC. | $198.13 | 2019-2025 | Erleada |
| Blue Earth Diagnostics | $188.74 | 2024-2025 | Posluma |
| Neotract INC. | $157.97 | 2019-2020 | |
| Abbvie INC. | $152.46 | 2023-2025 | |
| Teleflex LLC | $136.50 | 2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $135.67 | 2023-2024 | Prolaris |
| Boston Scientific Corporation | $100.66 | 2020-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Laborie Medical Technologies Corp. | $83.33 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $81.06 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.43 | 2019-2020 | |
| Coloplast Corp | $73.78 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $60.11 | 2020-2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $38.16 | 2022-2024 | |
| Pfizer INC. | $32.72 | 2020 | |
| Urogen Pharma, INC. | $26.03 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $22.69 | 2025 | Bard Urinary Drainage Bag |
| Olympus America INC. | $18.66 | 2021 | |
| Myovant Sciences INC. | $16.61 | 2021 | |
| Verity Pharmaceuticals INC. | $14.99 | 2022 | |
| Amgen INC. | $14.68 | 2022 | |
| Allergan, INC. | $14.42 | 2019 | |
| Rochester Medical Corporation | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Hollander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.